Stifel Financial’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,353
Closed -$90K 2401
2016
Q2
$90K Buy
1,353
+26
+2% +$1.65K ﹤0.01% 2393
2016
Q1
$75K Sell
1,327
-267
-17% -$30K ﹤0.01% 2137
2015
Q4
$375K Buy
1,594
+600
+60% +$131K ﹤0.01% 1808
2015
Q3
$159K Buy
994
+27
+3% +$7.64K ﹤0.01% 2078
2015
Q2
$366K Sell
967
-330
-25% -$131K ﹤0.01% 1853
2015
Q1
$543K Buy
1,297
+73
+6% +$26.1K ﹤0.01% 1580
2014
Q4
$335K Buy
+1,224
New +$304K ﹤0.01% 1815
2014
Q2
Sell
-15,595
Closed -$4.13M 2207
2014
Q1
$4.13M Buy
+15,595
New +$5.97M 0.04% 499

Other funds holding CLDX